highyield t7 mrna synthesis kit (Jena Bioscience)
Structured Review

Highyield T7 Mrna Synthesis Kit, supplied by Jena Bioscience, used in various techniques. Bioz Stars score: 93/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/highyield t7 mrna synthesis kit/product/Jena Bioscience
Average 93 stars, based on 12 article reviews
Images
1) Product Images from "Small nucleolar RNAs promote the restoration of muscle differentiation defects in cells from myotonic dystrophy type 1"
Article Title: Small nucleolar RNAs promote the restoration of muscle differentiation defects in cells from myotonic dystrophy type 1
Journal: Nucleic Acids Research
doi: 10.1093/nar/gkaf232
Figure Legend Snippet: Functional studies of SNORA40 and SNORA70 in muscle cells. Immunofluorescence in normal MT with (ASO CTRL) or without (ASOs SNORA40 and SNORA70) the presence of ( A ) SNORA40 and ( E ) SNORA70 ( n ≥ 3). Relative fusion index measured at 5 days post-differentiation after the loss of ( B ) SNORA40 and ( F ) SNORA70 in normal muscle cells. More than 800 nuclei per replicate were counted to calculate the fusion index ( n ≥ 3). Relative expression of the CCND3 and MYOG mRNA differentiation markers in normal muscle cells depleted in ( C ) SNORA40 and ( G ) SNORA70 ( n ≥ 3). Relative expression of the MYF5 and CCNB1 mRNA proliferation markers in normal muscle cells depleted in ( D ) SNORA40 and ( H ) SNORA70 ( n ≥ 3). Immunofluorescence in DM1 MT with plasmids expressing either a random sequence (Rd), ( I ) SNORA40 (SNORA40), or ( M ) SNORA70 ( n ≥ 3). Relative to the fusion index measured at 5 days post-differentiation after the gain of ( J ) SNORA40 and ( N ) SNORA70 in DM1 muscle cells. More than 800 nuclei per replicate were counted to calculate the fusion index ( n ≥ 3). Relative expression of the CCND3 and MYOG mRNA differentiation markers in DM1 muscle cells expressing ( K ) SNORA40 and ( O ) SNORA70 ( n ≥ 3). Relative expression of the MYF5 and CCNB1 mRNA proliferation markers in DM1 muscle cells expressing ( L ) SNORA40 and ( P ) SNORA70 ( n ≥ 3). ASO, gapmers; CTRL, control; Alpha-tub, alpha-tubulin; FI, fusion index; U6, RNU6; CCND3, Cyclin D3; MYOG, Myogenin; MYF5, Myogenic factor 5; CCNB1, Cyclin B1; d, day of differentiation. Scale bar = 10 μm. Error bars represent the standard error of the mean (SEM). * indicates P -value< .05. Significant differences were assessed by comparing the two conditions: ASO CTRL versus ASO SNORA40 at each corresponding time point. Statistical analyses were performed using a one-way ANOVA Fisher-means comparison test for the Fl results and a two-way ANOVA Tukey’s multiple comparisons test for the qPCR results.
Techniques Used: Functional Assay, Immunofluorescence, Expressing, Sequencing, Control, Comparison
Figure Legend Snippet: Interaction of CCND3 with SNORA70 and SNORA40. ( A and B ) Physical interaction of CCND3 with SNORA40 and SNORA70, respectively, as predicted with snoGPS software. Scores are indicated in bold. ( C ) The accumulation of CCND3 in the nucleoli. Isolation of nucleoli by sucrose cushion centrifugation was performed as described in . The total RNA from each fraction was extracted and the localization of CCND3 mRNA was assessed by RT-PCR ( n = 2). To confirm the correct isolation of the nucleoli, MALAT1 RNA and SNORD16 were used as nuclear (negative control) and nucleolar (positive control) markers, respectively. cDNA (50 ng of equivalent RNA) was used for each PCR reaction. ( D and E ) Direct interaction of CCND3 with SNORA40 and SNORA70, respectively. U6 and ACA36B were used as negative controls ( n = 2). ( F ) Immunoprecipitation (1 μg of RNA) of Psi in mRNA-enriched populations followed by RT-PCR. Five percent of the input was used. In vitro transcribed CCND3 RNA with and without pseudouridines were used as positive and negative controls, respectively ( n = 3). Ψ, Psi; T, total fraction; C, cytoplasmic fraction; N, nuclear fraction; Np, nucleoplasmic fraction; Nuc, nucleolar fraction; Blk, mock PCR; RNA PD, RNA pull-down; IP, Immunoprecipitation; Ig, immunoglobulin; 18S, rRNA 18S; SH3BGRL3, SH3 domain binding glutamic acid-rich-like protein 3.
Techniques Used: Software, Isolation, Centrifugation, Reverse Transcription Polymerase Chain Reaction, Negative Control, Positive Control, Immunoprecipitation, In Vitro, Binding Assay

15 ] C) Co‐immunoprecipitation (co‐IP) results showing the interactions between FLAG‐tagged NAT10 and HA‐tagged TDP43, PCBP1, and PCBP2, which were resistant to RNase A digestion. D) Endogenous immunoprecipitation (endo‐IP) results showing spontaneous coordination of TDP43, NAT10, and PCBP1/2 in 293T cells. Anti‐TDP43 antibody was applied in endo‐IP. Arrows indicated the beads band. E‐F) Diagram of N‐terminal truncated PCBP1/2 constructs and validation of the interaction between NAT10 and WT or mutant PCBPs. Co‐IP results indicated that the hnRNP K homology (KH) 1 domain in PCBP1/2 was responsible for their conjugation with NAT10. " width="250" height="auto" />